Elliot Tapper, MD FAASLD, will present the Leon Schiff State of the Art Lecture, "Symptom Science in Hepatology and a Future of Improved Outcomes." This lecture will explore the cutting-edge developments in symptom science within hepatology, emphasizing the critical role of understanding patient preferences in advancing care and improving outcomes. We will discuss the optimal and innovative tools for efficient determination of these preferences, enabling clinicians to tailor interventions to individual needs. We will highlight the methods and importance of patient-centered clinical trial design, ensuring that research is feasible and aligns with patient priorities.
Discuss the tools available to assess patient preferences related to their care for liver disease, and the impact of these approaches on patient outcomes.